Trials / Completed
CompletedNCT01108692
Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM)
Investigation on Early Detection and Active Management of Supra-ventricular Arrhythmia With Telecardiology
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 602 (actual)
- Sponsor
- Biotronik France · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates if the early detection and treatment of supraventricular arrhythmia (SVA) may help to prevent the progression of the arrhythmia and improve the clinical outcome. The primary endpoint investigates the delay to implement treatment in two groups of patients : * Active group: Patients followed by telecardiology. * Control group: Patients followed in the conventional manner. It is assumed that the delay to implement treatment will be higher in the Control group.
Detailed description
Atrial fibrillation is the most commonly encountered sustained cardiac arrhythmia in medical practice and it is often associated with atrial flutter. In patients with the new pacemaker generation EVIA, the home-monitoring technology provides specific and clinical relevant notifications for detection of atrial arrhythmias. Combined with holters memories, this can help to optimize the treatment of supraventricular arrhythmia (SVA) such as atrial fibrillation or flutter. This study will compare in the two groups the delay to implement for the first time a treatment for the supraventricular arrhythmia (antiarrhythmic drugs and/or an antithrombotic treatment).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Telecardiology | Telecardiology will be switched on for both groups. For the Active group, all data will be transmitted to the physician. For the Control group, data will not be used for patients surveillance, only events regarding implant (Elective Replacement Indication) or events regarding data transmission missing will be generated and sent to the physician. A retrospective analysis will be performed at the end of the study to compare the results in the two groups. |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2013-07-01
- Completion
- 2013-11-01
- First posted
- 2010-04-22
- Last updated
- 2013-12-06
Locations
57 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01108692. Inclusion in this directory is not an endorsement.